3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Renal Insufficiency, Chronic
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Interventions
Radiosurgery
11
Temozolomide
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
4
Mental Status and Dementia Tests
4
Receptors, Interleukin-8B
3
Memantine
3
Ipilimumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
Surveys and Questionnaires
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
pertuzumab
1
patritumab deruxtecan
1
nabiximols
1
fluciclovine F-18
1
entrectinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brodalumab
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Vorinostat
1
Vitamin B 6
1
Valacyclovir
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.